Finance

Beta
Lists
524632:BOM
Shukra Pharmaceuticals Ltd
₹31.46
+10.00%
(+2.86) 1D
Jun 5, 3:59:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524632...
Open
₹28.51
High
₹31.46
Low
₹28.51
Mkt. cap
13.83B
Avg. vol.
398.68K
Volume
896.97K
P/E ratio
62.92
52-wk high
₹65.26
52-wk low
₹12.97
EPS
₹0.50
No. of employees
115
Open
₹28.51
High
₹31.46
Low
₹28.51
Mkt. cap
13.83B
Avg. vol.
398.68K
Volume
896.97K
P/E ratio
62.92
52-wk high
₹65.26
52-wk low
₹12.97
EPS
₹0.50
No. of employees
115
News stories
From sources across the web
About Shukra Pharmaceuticals Ltd
CEO-
Employees115
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiteshukrapharmaceuticals.com
Last report
May 7, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
63.24M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
65.01M
75.90M
391.35M
63.24M
Cost of goods sold
7.70M
20.05M
71.34M
59.40M
Cost of revenue
7.70M
20.05M
71.34M
59.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.25M
21.93M
26.47M
3.72M
Operating expense
40.89M
51.02M
48.88M
-2.56M
Total operating expenses
48.60M
71.07M
120.22M
56.84M
Operating income
16.41M
4.83M
271.13M
6.40M
Other non operating income
-1.00K
1.00K
1.00K
1.00K
EBT including unusual items
13.73M
1.98M
268.31M
3.82M
EBT excluding unusual items
13.73M
1.98M
268.31M
3.82M
Income tax expense
3.44M
-21.80M
64.67M
20.98M
Effective tax rate
25.02%
-1,098.04%
24.10%
549.74%
Other operating expenses
14.77M
20.99M
14.02M
-16.35M
Net income
10.30M
23.78M
203.65M
-17.16M
Net profit margin
15.84%
31.33%
52.04%
-27.14%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.68M
-2.85M
-2.82M
-2.58M
Net interest expenses
-2.68M
-2.85M
-2.82M
-2.58M
Depreciation and amortization charges
7.87M
8.09M
8.39M
10.08M
EBITDA
23.93M
12.82M
278.64M
15.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer